|
Market Closed -
Euronext Paris
18:55:00 12/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 24.76 EUR | +1.31% |
|
-2.37% | -1.75% |
| 07-29 | Teva raises its guidance for Uzedy, Medincell benefits |  |
| 07-28 | Medincell Announces Board Resignations | CI |
| Market Cap | 889M 1.03B 833M 760M 1.43B 97.89B 1.45B 9.8B 3.83B 49.01B 3.85B 3.77B 163B | P/E 2027 * |
413x | P/E 2028 * | 52x |
|---|---|---|---|---|---|
| Enterprise Value | 874M 1.01B 819M 747M 1.4B 96.25B 1.43B 9.63B 3.77B 48.19B 3.79B 3.71B 161B | EV / Sales 2027 * |
19.8x | EV / Sales 2028 * | 14.6x |
| Free-Float |
66.02% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: MedinCell S.A.
| 1 day | +1.31% | ||
| 1 week | -2.37% | ||
| Current month | -4.55% | ||
| 1 month | -8.63% | ||
| 3 months | -10.22% | ||
| 6 months | +2.15% | ||
| Current year | -1.75% |
| 1 week | 23.98 |  | 25.18 |
| 1 month | 23.98 | | 27.36 |
| Current year | 19.69 | | 29.76 |
| 1 year | 16.1 | | 39.68 |
| 3 years | 5.25 | | 39.68 |
| 5 years | 4.73 | | 39.68 |
| 10 years | 4.35 | | 39.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 62 | 09/01/2003 |
Stéphane Postic
DFI | Director of Finance/CFO | 52 | 01/09/2023 |
Richard Malamut
CTO | Chief Tech/Sci/R&D Officer | 67 | 09/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Douat
BRD | Director/Board Member | 62 | 09/01/2003 |
Philippe Guy
CHM | Chairman | - | 13/03/2024 |
Virginie Lleu
BRD | Director/Board Member | - | 25/05/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/26/25 A | Buy | General Counsel | 2,943 | 0.0099% | ||
| 2/21/25 A | Buy | Chief Financial Officer | 3,749 | 0.0126% | ||
| 5/6/23 A | Sell | Founder | 60,000 | 0.2376% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.31% | -2.37% | +56.02% | +272.33% | 1.01B | |
| +0.43% | +4.31% | +90.84% | +130.99% | 1,083B | |
| +0.41% | +1.27% | +50.98% | +50.05% | 626B | |
| -0.53% | +1.04% | +25.23% | +63.46% | 442B | |
| -0.92% | +0.22% | +48.34% | +37.85% | 363B | |
| -1.32% | -0.21% | +29.07% | +36.81% | 295B | |
| -1.20% | -2.78% | +5.56% | +6.09% | 248B | |
| +0.45% | +2.05% | +46.04% | +58.54% | 224B | |
| -2.51% | +1.77% | -6.55% | -51.74% | 210B | |
| +0.07% | +3.12% | +13.21% | +69.84% | 168B | |
| Average | -0.38% | +1.13% | +35.87% | +67.42% | 366.01B | |
| Weighted average by Cap. | -0.26% | +2.19% | +49.22% | +66.02% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 44.14M 50.95M 41.36M 37.72M 70.92M 4.86B 72.01M 486M 190M 2.43B 191M 187M 8.11B | 58.92M 68.01M 55.21M 50.35M 94.67M 6.49B 96.12M 649M 254M 3.25B 255M 250M 10.83B |
| Net income | 667K 769K 625K 570K 1.07M 73.39M 1.09M 7.35M 2.87M 36.75M 2.89M 2.83M 123M | 13.33M 15.38M 12.49M 11.39M 21.41M 1.47B 21.74M 147M 57.4M 735M 57.75M 56.5M 2.45B |
| Net Debt | -14.87M -17.16M -13.93M -12.7M -23.89M -1.64B -24.25M -164M -64.04M -819M -64.43M -63.03M -2.73B | -30.53M -35.24M -28.61M -26.09M -49.06M -3.36B -49.81M -336M -132M -1.68B -132M -129M -5.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | €24.76 | +1.31% | 37,516 |
| 11/08/26 | €24.44 | +1.41% | 78,852 |
| 10/08/26 | €24.10 | -1.63% | 54,414 |
| 07/08/26 | €24.50 | -1.69% | 36,207 |
| 06/08/26 | €24.92 | -1.74% | 38,263 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDCL Stock
Select your edition
All financial news and data tailored to specific country editions
